These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 27717799)

  • 1. Reversed T Cell Receptor Docking on a Major Histocompatibility Class I Complex Limits Involvement in the Immune Response.
    Gras S; Chadderton J; Del Campo CM; Farenc C; Wiede F; Josephs TM; Sng XYX; Mirams M; Watson KA; Tiganis T; Quinn KM; Rossjohn J; La Gruta NL
    Immunity; 2016 Oct; 45(4):749-760. PubMed ID: 27717799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Canonical T cell receptor docking on peptide-MHC is essential for T cell signaling.
    Zareie P; Szeto C; Farenc C; Gunasinghe SD; Kolawole EM; Nguyen A; Blyth C; Sng XYX; Li J; Jones CM; Fulcher AJ; Jacobs JR; Wei Q; Wojciech L; Petersen J; Gascoigne NRJ; Evavold BD; Gaus K; Gras S; Rossjohn J; La Gruta NL
    Science; 2021 Jun; 372(6546):. PubMed ID: 34083463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of prominent peptide-major histocompatibility complex features limits repertoire diversity in virus-specific CD8+ T cell populations.
    Turner SJ; Kedzierska K; Komodromou H; La Gruta NL; Dunstone MA; Webb AI; Webby R; Walden H; Xie W; McCluskey J; Purcell AW; Rossjohn J; Doherty PC
    Nat Immunol; 2005 Apr; 6(4):382-9. PubMed ID: 15735650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topology of T cell receptor-peptide/class I MHC interaction defined by charge reversal complementation and functional analysis.
    Chang HC; Smolyar A; Spoerl R; Witte T; Yao Y; Goyarts EC; Nathenson SG; Reinherz EL
    J Mol Biol; 1997 Aug; 271(2):278-93. PubMed ID: 9268659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Force-Regulated In Situ TCR-Peptide-Bound MHC Class II Kinetics Determine Functions of CD4+ T Cells.
    Hong J; Persaud SP; Horvath S; Allen PM; Evavold BD; Zhu C
    J Immunol; 2015 Oct; 195(8):3557-64. PubMed ID: 26336148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hard wiring of T cell receptor specificity for the major histocompatibility complex is underpinned by TCR adaptability.
    Burrows SR; Chen Z; Archbold JK; Tynan FE; Beddoe T; Kjer-Nielsen L; Miles JJ; Khanna R; Moss DJ; Liu YC; Gras S; Kostenko L; Brennan RM; Clements CS; Brooks AG; Purcell AW; McCluskey J; Rossjohn J
    Proc Natl Acad Sci U S A; 2010 Jun; 107(23):10608-13. PubMed ID: 20483993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fixed expression of single influenza virus-specific TCR chains demonstrates the capacity for TCR α- and β-chain diversity in the face of peptide-MHC class I specificity.
    Clemens EB; Doherty PC; La Gruta NL; Turner SJ
    J Immunol; 2015 Feb; 194(3):898-910. PubMed ID: 25535284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structures of murine MHC Class I H-2 D(b) and K(b) molecules in complex with CTL epitopes from influenza A virus: implications for TCR repertoire selection and immunodominance.
    Meijers R; Lai CC; Yang Y; Liu JH; Zhong W; Wang JH; Reinherz EL
    J Mol Biol; 2005 Feb; 345(5):1099-110. PubMed ID: 15644207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spatial coordination of CD8 and TCR molecules controls antigen recognition by CD8+ T-cells.
    Pecht I; Gakamsky DM
    FEBS Lett; 2005 Jun; 579(15):3336-41. PubMed ID: 15913613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Affinity thresholds for naive CD8+ CTL activation by peptides and engineered influenza A viruses.
    Denton AE; Wesselingh R; Gras S; Guillonneau C; Olson MR; Mintern JD; Zeng W; Jackson DC; Rossjohn J; Hodgkin PD; Doherty PC; Turner SJ
    J Immunol; 2011 Dec; 187(11):5733-44. PubMed ID: 22039305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional evidence for TCR-intrinsic specificity for MHCII.
    Parrish HL; Deshpande NR; Vasic J; Kuhns MS
    Proc Natl Acad Sci U S A; 2016 Mar; 113(11):3000-5. PubMed ID: 26831112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A T Cell Receptor Locus Harbors a Malaria-Specific Immune Response Gene.
    Van Braeckel-Budimir N; Gras S; Ladell K; Josephs TM; Pewe L; Urban SL; Miners KL; Farenc C; Price DA; Rossjohn J; Harty JT
    Immunity; 2017 Nov; 47(5):835-847.e4. PubMed ID: 29150238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Constraints within major histocompatibility complex class I restricted peptides: presentation and consequences for T-cell recognition.
    Theodossis A; Guillonneau C; Welland A; Ely LK; Clements CS; Williamson NA; Webb AI; Wilce JA; Mulder RJ; Dunstone MA; Doherty PC; McCluskey J; Purcell AW; Turner SJ; Rossjohn J
    Proc Natl Acad Sci U S A; 2010 Mar; 107(12):5534-9. PubMed ID: 20212169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normalized Synergy Predicts That CD8 Co-Receptor Contribution to T Cell Receptor (TCR) and pMHC Binding Decreases As TCR Affinity Increases in Human Viral-Specific T Cells.
    Williams CM; Schonnesen AA; Zhang SQ; Ma KY; He C; Yamamoto T; Eckhardt SG; Klebanoff CA; Jiang N
    Front Immunol; 2017; 8():894. PubMed ID: 28804489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structures of high affinity human T-cell receptors bound to peptide major histocompatibility complex reveal native diagonal binding geometry.
    Sami M; Rizkallah PJ; Dunn S; Molloy P; Moysey R; Vuidepot A; Baston E; Todorov P; Li Y; Gao F; Boulter JM; Jakobsen BK
    Protein Eng Des Sel; 2007 Aug; 20(8):397-403. PubMed ID: 17644531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Highly divergent T-cell receptor binding modes underlie specific recognition of a bulged viral peptide bound to a human leukocyte antigen class I molecule.
    Liu YC; Miles JJ; Neller MA; Gostick E; Price DA; Purcell AW; McCluskey J; Burrows SR; Rossjohn J; Gras S
    J Biol Chem; 2013 May; 288(22):15442-54. PubMed ID: 23569211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Impact of MHC Class I Dose on Development and Maintenance of the Polyclonal Naive CD8
    Sng XYX; Li J; Zareie P; Assmus LM; Lee JKC; Jones CM; Turner SJ; Daley SR; Quinn KM; La Gruta NL
    J Immunol; 2020 Jun; 204(12):3108-3116. PubMed ID: 32341060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural basis for the killing of human beta cells by CD8(+) T cells in type 1 diabetes.
    Bulek AM; Cole DK; Skowera A; Dolton G; Gras S; Madura F; Fuller A; Miles JJ; Gostick E; Price DA; Drijfhout JW; Knight RR; Huang GC; Lissin N; Molloy PE; Wooldridge L; Jakobsen BK; Rossjohn J; Peakman M; Rizkallah PJ; Sewell AK
    Nat Immunol; 2012 Jan; 13(3):283-9. PubMed ID: 22245737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A T cell receptor flattens a bulged antigenic peptide presented by a major histocompatibility complex class I molecule.
    Tynan FE; Reid HH; Kjer-Nielsen L; Miles JJ; Wilce MC; Kostenko L; Borg NA; Williamson NA; Beddoe T; Purcell AW; Burrows SR; McCluskey J; Rossjohn J
    Nat Immunol; 2007 Mar; 8(3):268-76. PubMed ID: 17259989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The duration of TCR/pMHC interactions regulates CTL effector function and tumor-killing capacity.
    Riquelme E; Carreño LJ; González PA; Kalergis AM
    Eur J Immunol; 2009 Aug; 39(8):2259-69. PubMed ID: 19637198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.